Theresa Heggie
InvestorBiopharmaceutical Executive & Board Member at Invivo Capital Partners
About
Accomplished biotech and pharmaceutical executive who joined Freeline as CEO in 2020, with prior senior roles at Alnylam, Bupa, Shire, Baxter, and Janssen. She serves on the boards of BioCryst and ProQR Therapeutics and holds a BSc from Cornell University.
Colleagues at Invivo Capital Partners
Albert Ferrer
Partner at Invivo Capital Partners
Begoña Carreño
Chief Business Development Officer at Aspeya at Invivo Capital Partners
Borja Ruiz
Investment Analyst at Invivo Capital Partners
Cinta Diez
Investment Analyst at Invivo Capital Partners
Gemma Guinart
Principal at Invivo Capital Partners
Josep M. Martorell
Partner at Invivo Capital Partners
Laura Rodríguez
Partner at Invivo Capital Partners
Luis Pareras
Managing Partner at Invivo Capital Partners





